WO2014191197A1 - Stable cosmetic preparation - Google Patents

Stable cosmetic preparation Download PDF

Info

Publication number
WO2014191197A1
WO2014191197A1 PCT/EP2014/059718 EP2014059718W WO2014191197A1 WO 2014191197 A1 WO2014191197 A1 WO 2014191197A1 EP 2014059718 W EP2014059718 W EP 2014059718W WO 2014191197 A1 WO2014191197 A1 WO 2014191197A1
Authority
WO
WIPO (PCT)
Prior art keywords
ethylhexyl
acid
preparation
cosmetic preparation
ester
Prior art date
Application number
PCT/EP2014/059718
Other languages
German (de)
French (fr)
Inventor
Claire MATHIEU
Manuela Köhler
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of WO2014191197A1 publication Critical patent/WO2014191197A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients

Definitions

  • the present invention relates to a cosmetic preparation containing polysilicone-25 and 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrylene).
  • UV radiation causes a pigmentation in the sense of melanin formation.
  • the ultraviolet radiation of sunlight also has a damaging effect on the skin.
  • long-term damage such as an increased risk of developing skin cancer occurs due to excessive exposure to light from the UVB range (wavelength: 280-320 nm).
  • the excessive action of the UVB and UVA radiation also leads to a weakening of the elastic and collagen fibers of the connective tissue. This leads to numerous phototoxic and photoallergic reactions and leads to premature skin aging.
  • UVA and UVB filters are summarized in most industrialized countries in the form of positive lists such as Appendix 7 of the German Cosmetics Regulation.
  • Sunscreens are often used in conjunction with water sports activities (swimming, swimming, surfing, diving, etc.).
  • the SPF on the skin goes back with it.
  • the skin must therefore be regularly treated with sunscreen to maintain the UV protection.
  • film-forming agents are added to the formulations according to the prior art. However, these regularly lead to a sticky, sensory unattractive skin sensation.
  • the preparations are particularly waterproof and according to the invention particularly preferred embodiments, the measured SPF after contact with water is higher than after the direct application of the preparation to the skin.
  • the preparation according to the invention contains polysilicone-25 in a concentration of 0.1 to 2.0% by weight, based on the total weight of the preparation.
  • the preparation according to the invention contains polysilicone-25 in a concentration of 0.5 to 1.0% by weight, based on the total weight of the preparation.
  • Polysilicone-25 according to the invention can be used by Momentive under the
  • the preparation according to the invention contains 2-ethylhexyl-2-cyano-3,3-diphenylacrylate in a concentration of 2.0 to 12.0% by weight, based on the total weight of the composition. It is preferred according to the invention if the preparation according to the invention contains 2-ethylhexyl-2-cyano-3,3-diphenylacrylate in a concentration of 5.0 to 10.0% by weight, based on the total weight of the composition.
  • preparation always means the preparation according to the invention, unless otherwise stated.
  • the preparation according to the invention contains one or more additional UV filters.
  • the preparation according to the invention is preferably a cosmetic sunscreen.
  • the preparation according to the invention comprises one or more further UV filters selected from the group of the compounds phenylene-1,4-bis- (2-benzimidazyl) -
  • Methoxybenzalmalon- Acidon- Acidi (2-ethylhexyl) ester; 4-methoxycinnamate (2-ethylhexyl) ester; 4-methoxycinnamic acid isoamyl ester; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; homomenthyl; 2-ethylhexyl
  • Dioctylbutzlamidotriazone (INCI: diethylhexyl-butamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine having the (CAS No 288254-16-0); 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) (also: 2,4,6-tris [anilino] (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone); 2,4-bis - ⁇ [4- (2-ethyl-hexyloxy) -2
  • Triazine 2,4,6-tris- (biphenyl) -1, 3,5-triazine; 2,4-bis- (4'-di-neopentylaminobenzalmalonate) -6- (4 "_
  • Embodiments of the present invention which are particularly preferred according to the invention are characterized in that the preparation is free of 3- (4-methylbenzylidene) -camphor and 2-hydroxy-4-methoxybenzophenone (oxybenzone).
  • the preparation contains UV filters in the total amount of from 10 to 40% by weight, based on the total weight of the preparation. According to the invention, it is preferable if the preparation contains UV filters in the total amount of 12 to 30% by weight, based on the total weight of the preparation.
  • Embodiments of the present invention that are advantageous according to the invention are also characterized in that the preparation comprises one or more active substances selected from the group of the compounds glycyrrhetinic acid, urea, arctiin, alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine , Carnosine, caffeine, natural and / or synthetic isoflavonoids, glyceryl glucose, creatine, creatinine, taurine, ß-alanine and / or licochalcone A contains.
  • active substances selected from the group of the compounds glycyrrhetinic acid, urea, arctiin, alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine , Carnosine, caffeine, natural and / or synthetic isoflavonoids
  • the preparation according to the invention is present in the form of a W / O emulsion. It is inventively preferred if the preparation au except polysilicone 25 contains no further emulsifiers.
  • the oil phase of the preparation according to the invention is advantageously selected from the group of polar oils, for example from the group of lecithins and fatty acid triglycerides, namely the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 8 to 24, in particular 12 to 18 C Atoms.
  • the fatty acid triglycerides can be selected, for example, advantageously from the group of synthetic, semi-synthetic and natural oils, such as.
  • Cocoglyceride olive oil, sunflower oil, jojoba oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grapeseed oil, thistle oil, evening primrose oil, macadamia oil, and the like.
  • Berry wax, shea butter and / or lanolin (wool wax).
  • oil phase may advantageously be selected from the group of dicaprylyl ethers.
  • Olkomponenten are also z.
  • Butyloctylsalicylat for example, that available under the trade name Hallbrite BHB from the company. CP Hall
  • tridecyl salicylate which is available under the trade name Cosmacol ESI from Fa. Sasol
  • C1 2- C1 5 alkyl salicylate under the trade name Dermol NS at available from Alzo
  • hexadecyl benzoate and butyl octyl benzoate and mixtures thereof Hallstar AB.
  • Preferred embodiments of the present invention according to the invention are characterized in that the oil phase of the preparation cetearyl isononanoate, C1 2-1. 5
  • Alkyl benzoate and / or Ethylhexylcocoat contains.
  • the preparations according to the invention particularly preferably contain no dimethicone + dimethicone crosspolymer.
  • the aqueous phase of the preparations according to the invention may, in addition to water, advantageously contain customary cosmetic auxiliaries, for example alcohols, in particular those low C number such as ethanol, isopropanol, diols or polyols of low C number and their ethers, preferably propylene glycol, butylene glycol, 2-methylpropane-1, 3-diol, pentane-1, 2-diol, hexane-1, 2-diol , Octane-1, 2-diol, decane-1, 2-diol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products, electrolytes, etc
  • the preparation according to the invention may advantageously comprise consistency agents (gel formers,
  • Thickeners such as polyacrylates (also crosslinked) or
  • Cellulose derivatives for example, hydroxyethyl cellulose or others.
  • the preparation according to the invention contains ethanol.
  • the preparation according to the invention is characterized in that the preparation is propylene glycol, butylene glycol, 2-methylpropane-1, 3-diol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol and / or 1, 2-decanediol contains.
  • These diols / glycols are advantageously used according to the invention in a total amount of 0.25 to 4% by weight, based on the total weight of the preparation.
  • the preparation can be preserved with the usual preservatives used in cosmetics.
  • the preparation contains phenoxyethanol.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to a cosmetic preparation containing a) polysilicone-25 and b) 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrylene).

Description

Beschreibung  description
Stabile kosmetische Zubereitung Stable cosmetic preparation
Die vorliegende Erfindung betrifft eine kosmetische Zubereitung enthaltend Polysilicone-25 und 2-Ethylhexyl-2-cyano-3,3-diphenylacrylat (Octocrylene). The present invention relates to a cosmetic preparation containing polysilicone-25 and 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrylene).
Der Trend weg von der vornehmen Blässe hin zur„gesunden, sportlich braunen Haut" ist seit Jahren ungebrochen. Um diese zu erzielen setzen die Menschen ihre Haut der The trend away from the noble paleness to the "healthy, sporty brown skin" has been unbroken for years, to achieve this, people are putting their skin on the skin
Sonnenstrahlung aus, da diese eine Pigmentbildung im Sinne einer Melaninbildung hervorruft. Die ultraviolette Strahlung des Sonnenlichtes hat jedoch auch eine schädigende Wirkung auf die Haut. Neben der akuten Schädigung (Sonnenbrand) treten Langzeitschäden wie ein erhöhtes Risiko an Hautkrebs zu erkranken bei übermäßiger Bestrahlung mit Licht aus dem UVB-Bereich (Wellenlänge: 280-320 nm) auf. Die übermäßige Einwirkung der UVB- und UVA-Strahlung (Wellenlänge: 320-400 nm) führt darüber hinaus zu einer Schwächung der elastischen und kollagenen Fasern des Bindegewebes. Dies führt zu zahlreichen phototoxischen und photoallergischen Reaktionen und hat eine vorzeitige Hautalterung zur Folge. Solar radiation, as this causes a pigmentation in the sense of melanin formation. However, the ultraviolet radiation of sunlight also has a damaging effect on the skin. In addition to the acute injury (sunburn), long-term damage such as an increased risk of developing skin cancer occurs due to excessive exposure to light from the UVB range (wavelength: 280-320 nm). The excessive action of the UVB and UVA radiation (wavelength: 320-400 nm) also leads to a weakening of the elastic and collagen fibers of the connective tissue. This leads to numerous phototoxic and photoallergic reactions and leads to premature skin aging.
Zum Schutz der Haut wurden daher eine Reihe von Lichtschutzfiltersubstanzen entwickelt, die in kosmetischen Zubereitungen eingesetzt werden können. Diese UVA- und UVB-Filter sind in den meisten Industrieländern in Form von Positivlisten wie der Anlage 7 der deutschen Kosmetikverordnung zusammengefasst. To protect the skin, therefore, a number of sunscreen filter substances have been developed which can be used in cosmetic preparations. These UVA and UVB filters are summarized in most industrialized countries in the form of positive lists such as Appendix 7 of the German Cosmetics Regulation.
Die Vielzahl an kommerziell erhältlichen Sonnenschutzmitteln darf jedoch nicht darüber hinwegtäuschen, dass diese Zubereitungen des Standes der Technik eine Reihe von Nachteilen aufweisen. However, the variety of commercially available sunscreens must not obscure the fact that these prior art formulations have a number of disadvantages.
Sonnenschutzmittel werden häufig in Zusammenhang mit Wassersportaktivitäten (Baden, Schwimmen, Surfen, Tauchen etc.) verwendet. Dabei tritt das Problem auf, dass das Sonnenschutzmittel bei Kontakt mit Wasser im Laufe der Zeit von der Haut abgewaschen wird. Der Lichtschutzfaktor auf der Haut geht damit zurück. Die Haut muss daher regelmäßig mit Sonnenschutzmittel nachbehandelt werden, um den UV-Schutz aufrecht zu erhalten. Um die Anhaftung von Sonnenschutzmitteln auf der Haut zu erhöhen, werden nach dem Stand der Technik den Zubereitungen Filmbildner zugesetzt. Diese führen aber regelmäßig zu einem klebrigen, sensorisch unattraktiven Hautgefühl. Sunscreens are often used in conjunction with water sports activities (swimming, swimming, surfing, diving, etc.). The problem arises that the sunscreen on contact with water is washed off the skin over time. The SPF on the skin goes back with it. The skin must therefore be regularly treated with sunscreen to maintain the UV protection. To increase the adhesion of sunscreens to the skin, film-forming agents are added to the formulations according to the prior art. However, these regularly lead to a sticky, sensory unattractive skin sensation.
Es war daher die Aufgabe der vorliegenden Erfindung, die Nachteile des Standes der Technik zu beseitigen und ein Sonnenschutzmittel zu entwickeln, dass auch bei intensiven Kontakt mit Wasser einen hohen UV-Schutz gewährleistet. Darüber hinaus sollte dieses Sonnenschutzmittel ein attraktives, nicht klebriges Hautgefühl aufweisen. It was therefore the object of the present invention to eliminate the disadvantages of the prior art and to develop a sunscreen that ensures high UV protection even with intensive contact with water. In addition, this sunscreen should have an attractive, non-sticky feel on the skin.
Überraschend gelöst wird die Aufgabe durch eine kosmetische Zubereitung enthaltend a) Polysilicone-25 und Surprisingly, the object is achieved by a cosmetic preparation containing a) Polysilicone-25 and
b) 2-Ethylhexyl-2-cyano-3,3-diphenylacrylat (Octocrylene). b) 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrylene).
Insbesondere war es für den Fachmann überraschend und nicht vorhersehbar, dass die Zubereitungen besonders wasserfest sind und bei erfindungsgemäß besonders bevorzugten Ausführungsformen der gemessene Lichtschutzfaktor SPF nach dem Kontakt mit Wasser höher ist, als nach dem direkten Auftrag der Zubereitung auf die Haut. In particular, it was surprising and unpredictable for the person skilled in the art that the preparations are particularly waterproof and according to the invention particularly preferred embodiments, the measured SPF after contact with water is higher than after the direct application of the preparation to the skin.
Zwar kennt der Stand der Technik das Marketing Bulletin„Silform EOF emulsifier EO-free W/O-Emulsifier" der Firma Momentive, doch konnte diese Produktinformation nicht den Weg zur vorliegenden Erfindung weisen. Although the state of the art knows the marketing bulletin "Silform EOF emulsifier EO-free W / O emulsifier" by Momentive, this product information could not point the way to the present invention.
Es ist erfindungsgemäß vorteilhaft, wenn die erfindungsgemäße Zubereitung Polysilicone-25 in einer Konzentration von 0,1 bis 2,0 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, enthält. It is advantageous according to the invention if the preparation according to the invention contains polysilicone-25 in a concentration of 0.1 to 2.0% by weight, based on the total weight of the preparation.
Es ist erfindungsgemäß bevorzugt, wenn die erfindungsgemäße Zubereitung Polysilicone-25 in einer Konzentration von 0,5 bis 1 ,0 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, enthält. It is preferred according to the invention if the preparation according to the invention contains polysilicone-25 in a concentration of 0.5 to 1.0% by weight, based on the total weight of the preparation.
Das erfindungsgemäße Polysilicone-25 kann bei der Firma Momentive unter dem Polysilicone-25 according to the invention can be used by Momentive under the
Handelsnamen SILFORM EOF käuflich erworben werden. Trade names SILFORM EOF are commercially available.
Es ist erfindungsgemäß vorteilhaft, wenn die erfindungsgemäße Zubereitung 2-Ethylhexyl-2- cyano-3,3-diphenylacrylat in einer Konzentration von 2,0 bis 12,0 Gewichts-%, bezogen auf das Gesamtgewicht der Zusammensetzung, enthält. Es ist erfindungsgemäß bevorzugt, wenn die erfindungsgemäße Zubereitung 2-Ethylhexyl-2- cyano-3,3-diphenylacrylat in einer Konzentration von 5,0 bis 10,0 Gewichts-%, bezogen auf das Gesamtgewicht der Zusammensetzung, enthält. It is advantageous according to the invention if the preparation according to the invention contains 2-ethylhexyl-2-cyano-3,3-diphenylacrylate in a concentration of 2.0 to 12.0% by weight, based on the total weight of the composition. It is preferred according to the invention if the preparation according to the invention contains 2-ethylhexyl-2-cyano-3,3-diphenylacrylate in a concentration of 5.0 to 10.0% by weight, based on the total weight of the composition.
Im Rahmen der vorliegenden Offenbarung ist mit Zubereitung immer die erfindungsgemäße Zubereitung gemeint, wenn nichts anderes erwähnt ist. In the context of the present disclosure, preparation always means the preparation according to the invention, unless otherwise stated.
Es ist erfindungsgemäß vorteilhaft, wenn die erfindungsgemäße Zubereitung einen oder mehrere zusätzliche UV-Filter enthält. It is advantageous according to the invention if the preparation according to the invention contains one or more additional UV filters.
Erfindungsgemäß bevorzugt handelt es sich bei der erfindungsgemäßen Zubereitung um ein kosmetisches Sonnenschutzmittel. According to the invention, the preparation according to the invention is preferably a cosmetic sunscreen.
Es ist erfindungsgemäß vorteilhaft, wenn die erfindungsgemäße Zubereitung einen oder mehrere weitere UV-Filter gewählt aus der Gruppe der Verbindungen Phenylen-1 ,4-bis-(2- benzimidazyl)-It is advantageous according to the invention if the preparation according to the invention comprises one or more further UV filters selected from the group of the compounds phenylene-1,4-bis- (2-benzimidazyl) -
3,3'-5,5'-tetrasulfonsäuresalze; 2-Phenylbenzimidazol-5-sulfonsäuresalze; 1 ,4-di(2- oxo-10-Sulfo-3-bornylidenmethyl)-Benzol und dessen Salze; 4-(2-Oxo-3- bornylidenmethyl)ben25 3,3'-5,5'-tetrasulfonsäuresalze; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and its salts; 4- (2-oxo-3-bornylidenemethyl) ben25
zolsulfonsäuresalze; 2-Methyl-5-(2-oxo-3-bornylidenmethyl)sulfonsäuresalze; 2,2'-Methylen- bis-zolsulfonsäuresalze; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2,2'-methylene bis-
(6-(2H-benzotriazol-2-yl)-4-(1 ,1 ,3,3-tetramethylbutyl)-phenol); 2-(2H-benzotriazol-2-yl)-4- methyl-(6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); 2- (2H-benzotriazol-2-yl) -4-methyl
6-[2-methyl-3-[1 ,3,3,3-tetramethyl-1 -[(trimethylsilyl)oxy]disiloxanyl]propyl]-phenol; 3-(4- Methylbenzyliden)campher; 3-Benzylidencampher; Ethylhexylsalicylat; 2-(4'-Diethylamino-2'- hydoxybenzoyl)-benzoesäurehexylester; Terephthalidendicamphersulfonsäure; 4- 30 (Dimethylamino)-benzoesäure(2-ethylhexyl)ester; 4-(Dimethylamino)benzoesäure- amylester; 4-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] phenol; 3- (4-methylbenzylidene) camphor; 3-benzylidenecamphor; ethylhexyl salicylate; Hexyl 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate; Terephthalidendicamphersulfonsäure; 4-30 (dimethylamino) benzoic acid (2-ethylhexyl) ester; 4- (dimethylamino) benzoic acid amyl ester; 4
Methoxybenzalmalon-säuredi(2-ethylhexyl)ester; 4-Methoxyzimtsäure(2-ethylhexyl)ester; 4- Methoxyzimtsäureisoamylester; 2-Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-methoxy- 4'- methylbenzophenon; 2,2'-Dihydroxy-4-methoxybenzophenon; Homomenthylsalicylat; 2- Ethylhexyl-Methoxybenzalmalon-säuredi (2-ethylhexyl) ester; 4-methoxycinnamate (2-ethylhexyl) ester; 4-methoxycinnamic acid isoamyl ester; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; homomenthyl; 2-ethylhexyl
2-hydroxybenzoat;; Dimethicodiethylbenzalmalonat; 3-(4-(2,2-bis Ethoxycarbonylvinyl)- 35 phenoxy)propenyl)-methoxysiloxan / Dimethylsiloxan - Copolymer; 2-hydroxybenzoate ;; dimethicodiethylbenzalmalonate; 3- (4- (2,2-ethoxy-carbonyl-vinyl) -35-phenoxy) -propenyl) -methoxysiloxane / dimethylsiloxane copolymer;
Dioctylbutylamidotriazon (INCI: Diethylhexyl-Butamidotriazone); 2,4-bis-[5-1 (dimethylpropyl)benzoxazol-2-yl-(4- phenyl)- imino]-6-(2-ethylhexyl)-imino-1 ,3,5-triazin mit der (CAS Nr. 288254-16-0); 4,4',4"-(1 ,3,5- Triazin-2,4,6-triyltriimino)-tris-benzoesäure-tris(2-ethylhexylester) (auch: 2,4,6-Tris-[anilino-(p- carbo-2'- ethyl-1 '-hexyloxy)]-1 ,3,5-triazin (INCI: Ethylhexyl Triazone); 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2- hydroxy]- phenyl}-6-(4-methoxyphenyl)-1 ,3,5-triazin (INCI: Bis-Ethylhexyloxyphenol MethoxyphenylDioctylbutzlamidotriazone (INCI: diethylhexyl-butamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine having the (CAS No 288254-16-0); 4,4 ', 4 "- (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester) (also: 2,4,6-tris [anilino] (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone); 2,4-bis - {[4- (2-ethyl-hexyloxy) -2 - hydroxy] - phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl
Triazin); 2,4,6-Tris-(biphenyl)-1 ,3,5-triazin; 2,4-Bis-(4'- Di-neopentylaminobenzalmalonat)-6- (4"_ Triazine); 2,4,6-tris- (biphenyl) -1, 3,5-triazine; 2,4-bis- (4'-di-neopentylaminobenzalmalonate) -6- (4 "_
butylaminobenzoat)-5 s-triazin, 4-Dicyanomethylen-2,6-dimethyl-1 ,4-dihydropyridin-N- (ethyloxysulfatestersalz), Titandioxid, Zinkoxid, Merocyanine, Piperazinderivate enthält. Erfindungsgemäß besonders bevorzugte Ausführungsformen der vorliegenden Erfindung sind dadurch gekennzeichnet, dass die Zubereitung frei ist von 3-(4-Methylbenzyliden)- campher und 2-Hydroxy-4-methoxybenzophenon (Oxybenzon). butylaminobenzoate) -5-s-triazine, 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine N- (ethyloxysulfate ester salt), titanium dioxide, zinc oxide, merocyanines, piperazine derivatives. Embodiments of the present invention which are particularly preferred according to the invention are characterized in that the preparation is free of 3- (4-methylbenzylidene) -camphor and 2-hydroxy-4-methoxybenzophenone (oxybenzone).
Hinsichtlich der Einsatzkonzentrationen der UV-Filter ist es erfindungsgemäß vorteilhaft, wenn die Zubereitung UV-Filter in der Gesamtmenge von 10 bis 40 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, enthält. Erfindungsgemäß bevorzugt ist es, wenn die Zubereitung UV-Filter in der Gesamtmenge von 12 bis 30 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, enthält. With regard to the use concentrations of the UV filters, it is advantageous according to the invention if the preparation contains UV filters in the total amount of from 10 to 40% by weight, based on the total weight of the preparation. According to the invention, it is preferable if the preparation contains UV filters in the total amount of 12 to 30% by weight, based on the total weight of the preparation.
Erfindungsgemäß vorteilhafte Ausführungsformen der vorliegenden Erfindung sind auch dadurch gekennzeichnet, dass die Zubereitung einen oder mehrere Wirkstoffe gewählt aus der Gruppe der Verbindungen Gylcyrrhetinsäure, Harnstoff, Arctiin, alpha-Liponsäure, Folsäure, Phytoen, D-Biotin, Coenzym Q10, alpha-Glucosylrutin, Carnitin, Carnosin, Coffein, natürliche und/oder synthetische Isoflavonoide, Glycerylglucose, Kreatin, Kreatinin, Taurin, ß-Alanin und/oder Licochalcon A enthält. Embodiments of the present invention that are advantageous according to the invention are also characterized in that the preparation comprises one or more active substances selected from the group of the compounds glycyrrhetinic acid, urea, arctiin, alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine , Carnosine, caffeine, natural and / or synthetic isoflavonoids, glyceryl glucose, creatine, creatinine, taurine, ß-alanine and / or licochalcone A contains.
Erfindungsgemäß vorteilhaft liegt die erfindungsgemäße Zubereitung in Form einer W/O- Emulsion vor. Dabei ist es erfindungsgemäß bevorzugt, wenn die Zubereitung au ßer Polysilicone-25 keine weiteren Emulgatoren enthält. According to the invention, the preparation according to the invention is present in the form of a W / O emulsion. It is inventively preferred if the preparation au except polysilicone 25 contains no further emulsifiers.
Die Ölphase der erfindungsgemäßen Zubereitung wird vorteilhaft gewählt aus der Gruppe der polaren Öle, beispielsweise aus der Gruppe der Lecithine und der Fettsäuretriglyceride, namentlich der Triglycerinester gesättigter und/oder ungesättigter, verzweigter und/oder unverzweigter Alkancarbonsäuren einer Kettenlänge von 8 bis 24, insbesondere 12 bis 18 C- Atomen. Die Fettsäuretriglyceride können beispielsweise vorteilhaft gewählt werden aus der Gruppe der synthetischen, halbsynthetischen und natürlichen Öle, wie z. B. Cocoglycerid, Olivenöl, Sonnenblumenöl, Jojobaöl, Sojaöl, Erdnu ßöl, Rapsöl, Mandelöl, Palmöl, Kokosöl, Rizinusöl, Weizenkeimöl, Traubenkernöl, Distelöl, Nachtkerzenöl, Macadamianu ßöl und dergleichen mehr. The oil phase of the preparation according to the invention is advantageously selected from the group of polar oils, for example from the group of lecithins and fatty acid triglycerides, namely the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 8 to 24, in particular 12 to 18 C Atoms. The fatty acid triglycerides can be selected, for example, advantageously from the group of synthetic, semi-synthetic and natural oils, such as. Cocoglyceride, olive oil, sunflower oil, jojoba oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grapeseed oil, thistle oil, evening primrose oil, macadamia oil, and the like.
Erfindungsgemäß vorteilhaft sind ferner z. B. natürliche Wachse tierischen und pflanzlichen Ursprungs, wie beispielsweise Bienenwachs und andere Insektenwachse sowie Also advantageous according to the invention are z. B. natural waxes of animal and vegetable origin, such as beeswax and other insect waxes and
Beerenwachs, Sheabutter und/oder Lanolin (Wollwachs). Berry wax, shea butter and / or lanolin (wool wax).
Ferner kann die Ölphase vorteilhaft gewählt werden aus der Gruppe der Dicaprylylether enthalten. Furthermore, the oil phase may advantageously be selected from the group of dicaprylyl ethers.
Es ist ferner vorteilhaft, das oder die Olkomponenten aus der Gruppe Isoparaffine, It is also advantageous to use the oil component or components from the group of isoparaffins,
Isoeikosan, Neopentylglykoldiheptanoat, Propylenglykoldicaprylat/dicaprat, Capry- lic/Capric/Diglycerylsuccinat, Butylenglykol Dicaprylat/Dicaprat, Ci2-i3-Alkyllactat, Di-C1 2-13- Alkyltartrat, Triisostearin, Dipentaerythrityl Hexacaprylat/Hexacaprat, Propylenglykolmo- noisostearat, Tricaprylin, Dimethylisosorbid. Isoeicosane, neopentyl glycol, propylene glycol dicaprylate / dicaprate, caprylic lic / capric / diglyceryl succinate, butylene -i 3 alkyl lactate, di-C 1 2 -13- alkyl tartrate, triisostearin, Dipentaerythrityl noisostearat dicaprylate / dicaprate, C 2 Hexacaprylat / Hexacaprat, Propylenglykolmo-, Tricaprylin, dimethylisosorbide.
Vorteilhafte Olkomponenten sind ferner z. B. Butyloctylsalicylat (beispielsweise das unter der Handelsbezeichnung Hallbrite BHB bei der Fa. CP Hall erhältliche), Tridecylsalicylat (welches unter der Handelsbezeichnung Cosmacol ESI bei der Fa. Sasol erhältlich ist), C1 2- C1 5 Alkylsalicylat (unter der Handelsbezeichnung Dermol NS bei der Fa. Alzo erhältlich), Hexadecylbenzoat und Butyloctylbenzoat und Gemische davon (Hallstar AB). Advantageous Olkomponenten are also z. B. Butyloctylsalicylat (for example, that available under the trade name Hallbrite BHB from the company. CP Hall), tridecyl salicylate (which is available under the trade name Cosmacol ESI from Fa. Sasol), C1 2- C1 5 alkyl salicylate (under the trade name Dermol NS at available from Alzo), hexadecyl benzoate and butyl octyl benzoate and mixtures thereof (Hallstar AB).
Auch beliebige Abmischungen solcher Öl- und Wachskomponenten sind vorteilhaft im Sinne der vorliegenden Erfindung einzusetzen. Any mixtures of such oil and wax components are also advantageous to use in the context of the present invention.
Erfindungsgemäß bevorzugte Ausführungsformen der vorliegenden Erfindung sind dadurch gekennzeichnet, dass die Ölphase der Zubereitung Cetearylisononanoat, C1 2-1 5 Preferred embodiments of the present invention according to the invention are characterized in that the oil phase of the preparation cetearyl isononanoate, C1 2-1. 5
Alkylbenzoat und/oder Ethylhexylcocoat enthält. Alkyl benzoate and / or Ethylhexylcocoat contains.
Erfindungsgemäß besonders bevorzugt enthaltenden die erfindungsgemäßen Zubereitungen kein Dimethicone + Dimethicone Crosspolymer. According to the invention, the preparations according to the invention particularly preferably contain no dimethicone + dimethicone crosspolymer.
Die Wasserphase der erfindungsgemäßen Zubereitungen kann -neben Wasser- vorteilhaft übliche kosmetische Hilfsstoffe enthalten, wie beispielsweise Alkohole, insbesondere solche niedriger C-Zahl wie Ethanol, Isopropanol, Diole oder Polyole niedriger C-Zahl sowie deren Ether, vorzugsweise Propylenglykol, Butylenglykol, 2-Methylpropan-1 ,3-diol, Pentan-1 ,2-diol, Hexan-1 ,2-diol, Octan-1 ,2-diol, Decan-1 ,2-diol, Glycerin, Ethylenglykol, Ethylenglykolmono- ethyl- oder -monobutylether, Propylenglykolmonomethyl, -monoethyl- oder -monobutylether, Diethylenglykolmonomethyl- oder -monoethylether und analoge Produkte, Elektrolyte, etc.. Die erfindungsgemäße Zubereitung kann vorteilhaft Konsistenzbildner (Gelbildner, The aqueous phase of the preparations according to the invention may, in addition to water, advantageously contain customary cosmetic auxiliaries, for example alcohols, in particular those low C number such as ethanol, isopropanol, diols or polyols of low C number and their ethers, preferably propylene glycol, butylene glycol, 2-methylpropane-1, 3-diol, pentane-1, 2-diol, hexane-1, 2-diol , Octane-1, 2-diol, decane-1, 2-diol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products, electrolytes, etc The preparation according to the invention may advantageously comprise consistency agents (gel formers,
Verdickungsmittel) wie beispielsweise Polyacrylate (auch quervernetzt) oder Thickeners) such as polyacrylates (also crosslinked) or
Cellulosederivate (beispielsweise Hydroxyethylcellulose) oder andere enthalten. Cellulose derivatives (for example, hydroxyethyl cellulose) or others.
Es ist erfindungsgemäß bevorzugt, wenn die erfindungsgemäße Zubereitung Ethanol enthält. It is preferred according to the invention if the preparation according to the invention contains ethanol.
Erfindungsgemäß bevorzugt ist es, wenn die erfindungsgemäße Zubereitung dadurch gekennzeichnet ist, dass die Zubereitung Propylenglycol, Butylenglycol, 2-Methylpropan-1 ,3- diol, 1 ,2-Pentandiol, 1 ,2-Hexandiol, 1 ,2-Octandiol und/oder 1 ,2-Decandiol enthält. Dabei werden diese Diole/Glycole erfindungsgemäß vorteilhaft in einer Gesamtmenge von 0,25 bis 4 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, eingesetzt. According to the invention, it is preferred if the preparation according to the invention is characterized in that the preparation is propylene glycol, butylene glycol, 2-methylpropane-1, 3-diol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol and / or 1, 2-decanediol contains. These diols / glycols are advantageously used according to the invention in a total amount of 0.25 to 4% by weight, based on the total weight of the preparation.
Selbstverständlich kann die Zubereitung mit den üblichen, in der Kosmetik verwendeten Konservierungsmitteln konserviert werden. Of course, the preparation can be preserved with the usual preservatives used in cosmetics.
Dabei ist es erfindungsgemäß bevorzugt, wenn die Zubereitung Phenoxyethanol enthält. It is preferred according to the invention if the preparation contains phenoxyethanol.
Darüber hinaus ist es erfindungsgemäß bevorzugt, wenn die Zubereitung frei ist von Moreover, it is preferred according to the invention if the preparation is free from
Parabenen. Parabens.
Beispiele Examples
Die nachfolgenden Beispiele sollen die vorliegende Erfindung verdeutlichen, ohne sie einzuschränken. Alle Mengenangaben, Anteile und Prozentanteile sind, soweit nicht anders angegeben, auf das Gewicht und die Gesamtmenge bzw. auf das Gesamtgewicht der Zubereitungen bezogen.  The following examples are intended to illustrate the present invention without limiting it. Unless indicated otherwise, all amounts, proportions and percentages are based on the weight and the total amount or on the total weight of the preparations.
Figure imgf000008_0001
Figure imgf000008_0001

Claims

Patentansprüche Patent claims
Kosmetische Zubereitung enthaltend Containing cosmetic preparation
a) Polysilicone-25 und a) Polysilicone-25 and
b) 2-Ethylhexyl-2-cyano-3,3-diphenylacrylat (Octocrylene). b) 2-Ethylhexyl-2-cyano-3,3-diphenylacrylate (Octocrylene).
Kosmetische Zubereitung nach Anspruch 1 , dadurch gekennzeichnet, dass die Zubereitung Polysilicone-25 in einer Konzentration von 0,1 bis 2,0 Gewichts-%, bezogen auf das Gesamtgewicht der Zubereitung, enthält. Cosmetic preparation according to claim 1, characterized in that the preparation contains polysilicones-25 in a concentration of 0.1 to 2.0% by weight, based on the total weight of the preparation.
Kosmetische Zubereitung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung 2-Ethylhexyl-2-cyano-3,3-diphenylacrylat in einer Konzentration von 2 bis 12 Gewichts-%, bezogen auf das Gesamtgewicht der Zusammensetzung, enthält. Cosmetic preparation according to one of the preceding claims, characterized in that the preparation contains 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate in a concentration of 2 to 12% by weight, based on the total weight of the composition.
Kosmetische Zubereitung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung einen oder mehrere UV-Filter enthält, gewählt aus der Gruppe der Verbindungen 2-Phenylbenzimidazol-5-sulfonsäure und/oder deren Salze; Phenylen-1 ,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonsäuresalze; 1 ,4- di(2-oxo-10-Sulfo-3-bornylidenmethyl)-Benzol und dessen Salze; 4-(2-Oxo-3-bornyli- denmethyl)benzolsulfonsäuresalze; 2-Methyl-5-(2-oxo-3-bornylidenmethyl)sulfon- säuresalze; 2,2'-Methylen-bis-(6-(2H-benzotriazol-2-yl)-4-(1 ,1 ,3,3-tetramethylbutyl)- phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1 ,3,3,3-tetramethyl-1 -[(tri- methylsilyl)oxy]disiloxanyl]propyl]-phenol; 3-(4-Methylbenzyliden)campher; 3-Benzyli- dencampher; Ethylhexylsalicylat; Terephthalidendicamphersulfonsäure; 4-(tert.- Butyl)-4'-methoxydibenzoylmethan; 4-(Dimethylamino)-benzoesäure(2-ethylhexyl)- ester; 4-(Dimethylamino)benzoesäure-amylester; 4-Methoxybenzalmalon-säuredi(2- ethylhexyl)ester; 4-Methoxyzimtsäure(2-ethylhexyl)ester; 4-Methoxyzimtsäureiso- amylester; 2-Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-methoxy-4'- methylbenzophenon; 2,2'-Dihydroxy-4-methoxybenzophenon; 2-(4'-Diethylamino-2'- hydoxybenzoyl)-benzoesäurehexylester; Homomenthylsalicylat; 2-Ethylhexyl-2- hydroxybenzoat; Dimethicodiethylbenzalmalonat; 3-(4-(2, Cosmetic preparation according to one of the preceding claims, characterized in that the preparation contains one or more UV filters selected from the group of compounds 2-phenylbenzimidazole-5-sulfonic acid and/or salts thereof; Phenylene-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonic acid salts; 1,4-di(2-oxo-10-sulfo-3-bornylidenemethyl)-benzene and its salts; 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid salts; 2-Methyl-5-(2-oxo-3-bornylidenemethyl)sulfonic acid salts; 2,2'-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol); 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(tri-methylsilyl)oxy]disiloxanyl]propyl] -phenol; 3-(4-methylbenzylidene)camphor; 3-benzylidene camphor; ethylhexyl salicylate; terephthalidenedicamphorsulfonic acid; 4-(tert-butyl)-4'-methoxydibenzoylmethane; 4-(Dimethylamino)-benzoic acid (2-ethylhexyl) ester; 4-(Dimethylamino)benzoic acid amyl ester; 4-Methoxybenzalmalonic acid di(2-ethylhexyl) ester; 4-Methoxycinnamic acid (2-ethylhexyl) ester; 4-Methoxycinnamic acid isoamyl ester; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-Dihydroxy-4-methoxybenzophenone; 2-(4'-Diethylamino-2'-hydroxybenzoyl)-benzoic acid hexyl ester; homomenthyl salicylate; 2-ethylhexyl-2-hydroxybenzoate; dimethicodiethyl benzalmalonate; 3-(4-(2,
2-bis Ethoxycarbonylvinyl)- phenoxy)propenyl)-methoxysiloxan / Dimethylsiloxan - Copolymer; 2-bis-ethoxycarbonylvinyl)-phenoxy)propenyl)-methoxysiloxane/dimethylsiloxane copolymer;
Dioctylbutylamidotriazon (INCI: Diethylhexyl-Butamidotriazone); 2,4-bis-[5-1 (dimethyl- propyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1 ,3,5-triazin mit der (CAS Nr. 288254-16-0); 4,4',4"-(1 ,3,5-Triazin-2,4,6-triyltriimino)-tris-benzoesäure-tris- (2-ethylhexylester) (auch: 2,4,6-Tris-[anilino-(p-carbo-2'-ethyl-1 '-hexyloxy)]-1 ,3,5-triazin (INCI: Ethylhexyl Triazone); 2,4-Bis-{[4-(2-ethyl-hexyloxy)-2-hydroxy]-phenyl}-6- (4-methoxyphenyl)-1 , dioctylbutylamidotriazone (INCI: diethylhexyl-butamidotriazone); 2,4-bis-[5-1 (dimethyl-propyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazine with the ( CAS No. 288254-16-0); 4,4',4"-(1,3,5-triazine-2,4,6-triyltriimino)-tris-benzoic acid tris-(2-ethylhexyl ester) (also: 2,4,6-tris-[anilino -(p-carbo-2'-ethyl-1'-hexyloxy)]-1,3,5-triazine (INCI: Ethylhexyl Triazone); 2,4-Bis-{[4-(2-ethyl-hexyloxy)- 2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,
3,5-triazin; 2,3,5-triazine; 2,
4,6-Tribiphenyl-4-yl-1 ,3,5-triazin; Merocyanine. 4,6-Tribiphenyl-4-yl-1,3,5-triazine; Merocyanines.
5. Kosmetische Zubereitung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, dass die Zubereitung einen oder mehrere Wirkstoffe gewählt aus der Gruppe der Verbindungen Gylcyrrhetinsäure, Harnstoff, Arctiin, alpha-Liponsäure, Folsäure, Phytoen, D-Biotin, Coenzym Q10, alpha-Glucosylrutin, Carnitin, Carnosin, Coffein, natürliche und/oder synthetische Isoflavonoide, Glycerylglucose, Kreatin, Kreatinin, Taurin, ß-Alanin und/oder Licochalcon A enthält. 5. Cosmetic preparation according to one of the preceding claims, characterized in that the preparation has one or more active ingredients selected from the group of compounds glycyrrhetinic acid, urea, arctin, alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin , carnitine, carnosine, caffeine, natural and/or synthetic isoflavonoids, glyceryl glucose, creatine, creatinine, taurine, ß-alanine and/or licochalcone A.
6. Kosmetische Zubereitung nach einem der vorhergehenden Ansprüche, dadurch 6. Cosmetic preparation according to one of the preceding claims, characterized
gekennzeichnet, dass die Zubereitung Propylenglycol, Butylenglycol, 2- Methylpropan-1 ,3-diol, 1 ,2-Pentandiol, 1 ,2-Hexandiol, 1 ,2-Octandiol und/oder 1 ,2- Decandiol enthält. characterized in that the preparation contains propylene glycol, butylene glycol, 2-methylpropane-1,3-diol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol and/or 1,2-decanediol.
7. Kosmetische Zubereitung nach einem der vorhergehenden Ansprüche, dadurch 7. Cosmetic preparation according to one of the preceding claims, characterized
gekennzeichnet, dass die Zubereitung in Form einer W/O-Emulsion vorliegt. characterized in that the preparation is in the form of a W/O emulsion.
8. Kosmetische Zubereitung nach einem der vorhergehenden Ansprüche, dadurch 8. Cosmetic preparation according to one of the preceding claims, characterized
gekennzeichnet, dass die Ölphase der Zubereitung Cetearylisononanoat, C12-15 Alkylbenzoat und/oder Ethylhexylcocoat enthält. characterized in that the oil phase of the preparation contains cetearyl isononanoate, C12-15 alkyl benzoate and / or ethylhexyl cocoate.
9. Kosmetische Zubereitung nach einem der vorhergehenden Ansprüche, dadurch 9. Cosmetic preparation according to one of the preceding claims, characterized
gekennzeichnet, dass die Zubereitung Ethanol enthält. characterized that the preparation contains ethanol.
10. Kosmetische Zubereitung nach einem der vorhergehenden Ansprüche, dadurch 10. Cosmetic preparation according to one of the preceding claims, characterized
gekennzeichnet, dass die Zubereitung frei ist von Parabenen. characterized that the preparation is free of parabens.
PCT/EP2014/059718 2013-05-28 2014-05-13 Stable cosmetic preparation WO2014191197A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102013209927.4 2013-05-28
DE201310209927 DE102013209927A1 (en) 2013-05-28 2013-05-28 Stable cosmetic preparation

Publications (1)

Publication Number Publication Date
WO2014191197A1 true WO2014191197A1 (en) 2014-12-04

Family

ID=50729497

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2014/059718 WO2014191197A1 (en) 2013-05-28 2014-05-13 Stable cosmetic preparation

Country Status (2)

Country Link
DE (1) DE102013209927A1 (en)
WO (1) WO2014191197A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106560174A (en) * 2015-10-01 2017-04-12 拜尔斯道夫股份有限公司 Sunscreen with reduced fabric staining caused by diethylamino hydroxybenzoyl hexyl benzoate
CN107028790A (en) * 2015-10-01 2017-08-11 拜尔斯道夫股份有限公司 Sunscreen with reduced fabric staining caused by bis-ethylhexyloxyphenol methoxyphenyl triazine
CN111556742A (en) * 2017-11-10 2020-08-18 株式会社爱茉莉太平洋 UV-blocking cosmetic composition comprising positively charged oil
US10821059B2 (en) 2015-12-31 2020-11-03 Colgate-Palmolive Company Cleansing bars

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015225567A1 (en) * 2015-12-17 2017-06-22 Beiersdorf Ag New sunscreens with starting material for the formation of 4- (tert-butyl) -4'-methoxydibenzoylmethane

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2438903A2 (en) * 2010-10-07 2012-04-11 Beiersdorf AG Preservative-free sunscreen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006055040A1 (en) * 2006-11-17 2008-05-21 Beiersdorf Ag Cosmetic preparations with high glycerine content
DE102006055016A1 (en) * 2006-11-17 2008-05-21 Beiersdorf Ag Cosmetic preparations with Guerbet alcohols

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2438903A2 (en) * 2010-10-07 2012-04-11 Beiersdorf AG Preservative-free sunscreen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "SILFORM* EOF emulsifier EO-free W/O-Emulsifier (Marketing Bulletin)", 31 December 2012 (2012-12-31), pages 1 - 12, XP002727710, Retrieved from the Internet <URL:http://www.google.de/url?url=http://www.momentive.com/workarea/downloadasset.aspx%3Fid%3D26563&rct=j&frm=1&q=&esrc=s&sa=U&ei=DbbQU-itGKKi4gTHnoHwCQ&ved=0CBoQFjAB&sig2=p_OtbwPzjDSlyTGOU9jxPA&usg=AFQjCNE9iQV1m8H23gQFfFtIatK3tRQjkA> [retrieved on 20140724] *
DATABASE IP.COM [online] 7 August 2012 (2012-08-07), "W/O emulsifier for suncare", XP013153055, Database accession no. IPCOM000220565D *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106560174A (en) * 2015-10-01 2017-04-12 拜尔斯道夫股份有限公司 Sunscreen with reduced fabric staining caused by diethylamino hydroxybenzoyl hexyl benzoate
CN107028790A (en) * 2015-10-01 2017-08-11 拜尔斯道夫股份有限公司 Sunscreen with reduced fabric staining caused by bis-ethylhexyloxyphenol methoxyphenyl triazine
US10821059B2 (en) 2015-12-31 2020-11-03 Colgate-Palmolive Company Cleansing bars
US11179304B2 (en) 2015-12-31 2021-11-23 Colgate-Palmolive Company Cleansing bars
CN111556742A (en) * 2017-11-10 2020-08-18 株式会社爱茉莉太平洋 UV-blocking cosmetic composition comprising positively charged oil

Also Published As

Publication number Publication date
DE102013209927A1 (en) 2014-12-04

Similar Documents

Publication Publication Date Title
EP2630990B1 (en) Lightweight, waterproof cosmetic preparation
EP2485805B1 (en) Cosmetic preparation containing cetearyl sulfosuccinates and trisbiphenyl triazine
EP3182954A1 (en) Stable cosmetic preparation
WO2014191197A1 (en) Stable cosmetic preparation
EP3003260B1 (en) Cosmetic preparation containing polysilicone-25 and water-soluble uv-filters with a sulfonic acid function
WO2015150115A1 (en) Cosmetic preparation for uv-protection based on acrylate
WO2014012705A2 (en) New cosmetic sunscreen spray
EP2438903B1 (en) Preservative-free sunscreen
EP2485806B1 (en) Use of cetearyl sulfosuccinates in sunscreen preparations
EP3125860B1 (en) Cosmetic preparations for uv protection on the basis of acrylate copolymers
EP2496309B1 (en) Cosmetic preparation containing cetearyl sulfocsuccinates and comprising liquid uv filters
DE202006011832U1 (en) Cosmetic composition, useful e.g. to protect skin from aging, comprises acrylonitrile compound e.g. 2-benzoyl-3-(4-methoxy-phenyl)-acrylonitrile and anionic emulgator
DE202006011471U1 (en) Cosmetic preparation, as sun protecting agent and to protect from skin aging, comprises (2-hydroxyethyl) urea and UV-light protection filter e.g. 1,4-di(2-oxo-10-sulfo-3-bornylidenmethyl)-benzol and 3-(4-methylbenzyliden)campher
EP2468362B1 (en) Cosmetic preparation with a UVA-filter and sodium cetearyl sulfate
DE102007017438A1 (en) Stable cosmetic preparation, specifically sun-protective or antiaging preparation for skin treatment, contains 2-propylheptyl octanoate and dimethicone diethyl benzalmalonate
DE102007024343A1 (en) Multiphase cosmetic preparation with an aqueous outer phase, useful as sunscreen, comprises metal oxide-pigment of titanium dioxide and/or zinc oxide, and a polyorganosiloxane copolymer with a statistical distribution
EP2451535A2 (en) Cosmetic preparation containing glycyrrhetinic acid
EP2630947B1 (en) Stable perfume, waterproof cosmetic preparation
EP3125863A1 (en) Method for protecting the skin from uv radiation
DE102012200072A1 (en) Cosmetic composition useful e.g. as skin care and decorative cosmetic, comprises 2,2-bis(((1-oxoisooctadecyl)oxy)methyl)-1,3-propanediyl-bis(isooctadecanoate), ultraviolet light protective filter comprising salicylates, and perfume

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14724072

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14724072

Country of ref document: EP

Kind code of ref document: A1